Want to join the conversation?
$TMO's Diagnostics and Healthcare end-market businesses performance in 3Q15 was pretty much similar to what it has seen in the 1H15 with growth in the low single digits. The key contributors in 3Q15 were its Clinical Diagnostics business and Healthcare market channel, which continue to grow well.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?